News Biotech eyes Chinese opportunities and seek local partners Biotech companies see China as one of the biggest healthcare opportunities, but would need partnerships before approaching the market, a new report suggests.
Partner Content Partner Content INC Research/inVentiv Health Becomes Syneos Health New Identity Signifies Industry’s Only Fully Integrated, End-to-End Biopharmaceutical Solutions Organization
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.